Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
MKGAF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
-19%
1.96
vs 2.41
Q2.23
-15%
2.4
vs 2.81
Q3.23
-31%
1.85
vs 2.68
Q4.23
-14%
1.99
vs 2.32
Q1.24
-11%
1.74
vs 1.96
Q2.24
-37%
1.51
vs 2.4
Q3.24
+38%
2.56
vs 1.85
Q4.24
-20%
1.59
vs 1.99
Q1.25
+27%
2.2
vs 1.74
Q2.25
+62%
2.45
vs 1.51
Sales Growth
YoY
Current
Estimates
Q1.23
+2%
5.3B vs 5.2B
Q2.23
-5%
5.3B vs 5.6B
Q3.23
-11%
5.2B vs 5.8B
Q4.23
-8%
5.2B vs 5.7B
Q1.24
-3%
5.1B vs 5.3B
Q2.24
+1%
5.4B vs 5.3B
Q3.24
+2%
5.3B vs 5.2B
Q4.24
+4%
5.4B vs 5.2B
Q1.25
+12%
5.8B vs 5.1B
Q2.25
+17%
6.3B vs 5.4B
Return on Equity
QoQ
Q1.23
+3%
0.03
vs 0.03
Q2.23
+3%
0.03
vs 0.03
Q3.23
+3%
0.03
vs 0.03
Q4.23
+2%
0.02
vs 0.03
Q1.24
+2%
0.02
vs 0.02
Q2.24
+2%
0.02
vs 0.02
Q3.24
+3%
0.03
vs 0.02
Q4.24
+2%
0.02
vs 0.03
Institutionnal Ownership
reuters.com
1 hour ago
reuters.com
9 hours ago
zacks.com
10 hours ago
seekingalpha.com
12 hours ago
youtube.com
13 hours ago
Quote Panel
Key Metrics
Relative Strength
MKGAF
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
PNK
5.46Â ( 4.10%)
Relative Strenght
Volume Buzz
-55%
Earning Acce
No
Dist 52w H.
31%Forecast
361%2025-Revenue
560%2025-EPS
400%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available